TAK-715
TAK-715 is a selective small molecule inhibitor targeting the p38α MAP kinase. It has been utilized in research to investigate p38α's role in cellular stress responses and inflammation, with applications in both in vitro biochemical assays and in vivo models of inflammatory disease.
Product Specifications
CAS Number
303162-79-0
Product Name Alternative
TAK 715, TAK1, TAK715, TAK-715, Snai1, Wnt/β-catenin, TNF-α, p38α, p38MAPK, p38δ, p38β, p38γ, p38 MAPK, orally, inhibit, JNK1, ERK1, IKKβ, MEKK1, hDvl2, Inhibitor, CYP3A4, CTGF, arthritis, CaseinKinase, Casein Kinase
Field of Research
Epigenetics & Chromatin, Metabolism Research, Signal Transduction, Stem Cell & Developmental Biology
Purity
98.51% (May vary between batches)
Solubility
Ethanol:20 mg/mL (50.06 mM) ; DMSO:50 mg/mL (125.15 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.01 mM)
Smiles
CCc1nc (c (s1) -c1ccnc (NC (=O) c2ccccc2) c1) -c1cccc (C) c1
Molecular Formula
C24H21N3OS
Molecular Weight
399.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS632746-01 0.5 mg
CD3, epsilon (Early T Cell Marker) (Azide Free)
Sign In for Pricing
View Details